Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Alder Therapeutics AB
AB
Active
Org 5593552762
Vasagatan 28, 111 20
Stockholm
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2021 · 4 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Alder Therapeutics AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
EBITDA
SEK millions
0M
-6M
-11M
-17M
-22M
2022: -4M
-4M
2022
2023: -18M (-350% vs 2022)
-18M
-350%
2023
2024: -8M (+56% vs 2023)
-8M
+56%
2024
Income statement
SEK thousands
Item
2024
2023
2022
Revenue
0
20
216
Staff expenses
—
—
—
EBITDA
−7 758
−17 909
−3 570
Depreciation & amort.
−0
−0
−0
EBIT
−7 758
−17 909
−3 570
Net financials
−177
321
21
Profit before tax
−7 935
−17 589
−3 549
Tax
−0
−0
−0
Net profit
−7 935
−17 589
−3 549
Balance sheet
SEK thousands
Item
2024
2023
2022
Total assets
14 680
14 128
17 311
Equity
5 252
13 187
16 414
Long-term debt
8 000
0
0
Short-term debt
1 427
941
897
Total debt
9 427
941
897
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2022
2024
Equity ratio
35,8 %
This company
38,2 %
Market median
This company
Market median
6% below market
2022
2024
Return on equity
−151,1 %
This company
18,4 %
Market median
This company
Market median
921% below market
2022
2024
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2022
2024
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2022
2024
Debt / equity
1,80×
This company
0,62×
Market median
This company
Market median
190% above market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-12-01 – 2022-12-31
View
PDF
More on Alder Therapeutics AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
